NDC 50564-507 - Butalbital, Aspirin, Caffeine and Codeine Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50564-507
- Package NDCs from labels
- 50564-507-01, 50564-507-05
- Manufacturer
- Lannett Company, Inc. | Jerome Stevens Pharmaceuticals, Inc.
- Effective date
- 2012-05-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE CAPSULES, USP CIII Rx ONLY | Lannett Company, Inc. | Jerome Stevens Pharmaceuticals, Inc. | 2012-05-04 | HUMAN PRESCRIPTION DRUG LABEL |
| Codeine Phosphate - Jerome Stevens Pharmaceuticals | Jerome Stevens Pharmaceuticals | 2007-10-25 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50564-507-01 | Butalbital, Aspirin, Caffeine and Codeine Phosphate | 100 in 1 BOTTLE, PLASTIC | CAPSULE | 100 | 1 | |
| 50564-507-05 | Butalbital, Aspirin, Caffeine and Codeine Phosphate | 500 in 1 BOTTLE, PLASTIC | CAPSULE | 500 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50564-507 | BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE (BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE) CAPSULE [JEROME STEVENS PHARMACEUTICALS] | 1 | 2 package rows | 20071101_c8b93fc1-472c-4890-8d02-2ee4f7175c22.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.